Last update 04 Jun 2025

UB-551

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
An Innovative, Long-Acting IFNα8 (UBI Pharma), UB 551, UB-551
+ [1]
Target
IFNA8
Action
modulators
Mechanism
IFNA8 modulators(interferon alpha 8 modulators)
Therapeutic Areas
NeoplasmsInfectious DiseasesCardiovascular Diseases+ [8]
Active Indication
Behcet SyndromeEsophageal Squamous Cell CarcinomaBreast Cancer+ [6]
Inactive Indication-
Originator Organization
UBI Pharma Inc.UBI Pharma Inc.
Active Organization
UBI Pharma Inc.UBI Pharma Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with UB-551
Login to view more data
100 Translational Medicine associated with UB-551
Login to view more data
100 Patents (Medical) associated with UB-551
Login to view more data
100 Deals associated with UB-551
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Behcet SyndromePreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
01 Feb 2025
Esophageal Squamous Cell CarcinomaPreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
01 Feb 2025
Breast CancerPreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
30 Nov 2022
Colorectal CancerPreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
30 Nov 2022
Hepatitis BPreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
30 Nov 2022
Hepatitis CPreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
30 Nov 2022
MelanomaPreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
30 Nov 2022
Ovarian CancerPreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
30 Nov 2022
Prostatic CancerPreclinical
Taiwan Province
UBI Pharma Inc.UBI Pharma Inc.
30 Nov 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free